Free Trial

SNDL's (SNDL) Sell (D-) Rating Reaffirmed at Weiss Ratings

SNDL logo with Medical background

Key Points

  • SNDL's stock has been reaffirmed with a "sell (D-)" rating by Weiss Ratings, indicating ongoing lack of confidence from analysts.
  • Recent stock performance has shown a slight decline of 0.8%, with shares opening at $2.63 and an average price target of $4.50.
  • Institutional investors have made significant moves, with firms like Quantbot Technologies increasing their holdings by 815%, highlighting potential investment interest despite the negative ratings.
  • MarketBeat previews the top five stocks to own by November 1st.

SNDL (NASDAQ:SNDL - Get Free Report)'s stock had its "sell (d-)" rating reissued by Weiss Ratings in a research report issued to clients and investors on Wednesday,Weiss Ratings reports.

Several other research analysts also recently commented on SNDL. Wall Street Zen downgraded shares of SNDL from a "buy" rating to a "hold" rating in a research note on Saturday, October 4th. Alliance Global Partners initiated coverage on shares of SNDL in a research note on Wednesday, September 3rd. They set a "buy" rating and a $5.00 price target on the stock. One research analyst has rated the stock with a Buy rating and one has assigned a Sell rating to the company. Based on data from MarketBeat.com, the stock currently has an average rating of "Hold" and an average price target of $4.50.

Get Our Latest Report on SNDL

SNDL Trading Down 0.8%

SNDL stock opened at $2.63 on Wednesday. The company has a market capitalization of $691.11 million, a PE ratio of -9.74 and a beta of 3.83. SNDL has a one year low of $1.15 and a one year high of $2.79. The company's 50 day moving average price is $2.32 and its two-hundred day moving average price is $1.70. The company has a debt-to-equity ratio of 0.11, a quick ratio of 3.36 and a current ratio of 5.03.

SNDL (NASDAQ:SNDL - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The company reported $0.01 EPS for the quarter, topping the consensus estimate of ($0.04) by $0.05. The firm had revenue of $179.78 million for the quarter, compared to the consensus estimate of $231.50 million. SNDL had a negative net margin of 10.38% and a negative return on equity of 8.58%. As a group, analysts predict that SNDL will post -0.09 earnings per share for the current fiscal year.

Institutional Inflows and Outflows

Institutional investors and hedge funds have recently made changes to their positions in the company. Connor Clark & Lunn Investment Management Ltd. bought a new position in shares of SNDL in the first quarter worth approximately $30,000. Quantbot Technologies LP boosted its holdings in SNDL by 815.0% in the first quarter. Quantbot Technologies LP now owns 21,667 shares of the company's stock valued at $31,000 after acquiring an additional 19,299 shares in the last quarter. Hilton Capital Management LLC bought a new stake in SNDL in the second quarter valued at $30,000. R Squared Ltd boosted its holdings in SNDL by 722.2% in the first quarter. R Squared Ltd now owns 35,520 shares of the company's stock valued at $50,000 after acquiring an additional 31,200 shares in the last quarter. Finally, Oxford Asset Management LLP bought a new stake in SNDL in the second quarter valued at $44,000.

SNDL Company Profile

(Get Free Report)

SNDL Inc engages in the production, distribution, and sale of cannabis products in Canada. The company operates through Liquor Retail, Cannabis Retail, Cannabis Operations, and Investments segments. It engages in the cultivation, distribution, and sale of cannabis for the adult-use and medical markets; sells wines, beers, and spirits through wholly owned liquor stores; and private sale of recreational cannabis through wholly owned and franchised retail cannabis stores.

Recommended Stories

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in SNDL Right Now?

Before you consider SNDL, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and SNDL wasn't on the list.

While SNDL currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

The Next 7 Blockbuster Stocks for Growth Investors Cover

Wondering what the next stocks will be that hit it big, with solid fundamentals? Enter your email address to see which stocks MarketBeat analysts could become the next blockbuster growth stocks.

Get This Free Report
Like this article? Share it with a colleague.